TOP特許意匠商標
商標ウォッチ Twitter
公開日2024-12-04
公報種別公開国際商標公報
国際登録番号1812649
国際登録日2024-08-23
区分第5類(薬剤),第42類(科学・技術)
商品役務Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use.,Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research全 22 件を表示, experimentation, development, and analysis; advice, information and assistance relating to the foregoing.
基礎出願番号019002624
基礎出願日2024-03-21
基礎出願国EM
出願人Nordic Bioscience A/S
OCRテキストnordicEndotrophin
OCRテキスト2nordicEndotrophin
OCRについて
この商標をJ-PlatPatで参照する
Flag Counter

関連商標

Novo Nordisk A/S
Zilconyc
15日前
Suninflam Ltd.
suninflam
8日前
Merck Sharp & Dohme B.V.
BARLANZUS
15日前
Daily & Co.
TITAD
22日前
DATUM BIOTECH LTD
OSSIXSOFT
22日前
LuMit Co., Ltd.
LuMit
22日前
Boehringer Ingelheim International GmbH
MEVORIG
22日前
Boehringer Ingelheim International GmbH
TUSIRO
22日前
Kite Pharma, Inc.
KITE
22日前
Solarea Bio, Inc.
JOURNA
15日前
BIODERMIS LLC
BIOCORNEUM
15日前
ManaT Bio, Inc.
CLASPTHERAPEUTICS
15日前
CLEARLEAF INC.
CLEARLEAF
15日前
Therini Bio, Inc.
THERINIBIO
15日前
Merck Sharp & Dohme B.V.
BARZALVO
15日前
Merck Sharp & Dohme B.V.
CYPTRUCE
15日前
Merck Sharp & Dohme B.V.
CYPLIXITY
15日前
Novatek Pharmaceuticals, Inc.
OMATEK
22日前
Merck Sharp & Dohme B.V.
PRIZULIO
15日前
Merck Sharp & Dohme B.V.
CYPZURAS
15日前
Merck Sharp & Dohme B.V.
CYPTAVOS
15日前
Neurocrine Biosciences, Inc.
15日前
Neurocrine Biosciences, Inc.
"
15日前
Bridgebio Pharma, Inc.
15日前
NOVARTIS AG
15日前
NOVARTIS AG
JULRAYSI
15日前
NOVARTIS AG
VYHOPNU
15日前
NOVARTIS AG
ULKEPZO
15日前
NOVARTIS AG
KLYBEZ
15日前
NOVARTIS AG
AFZEYL
15日前
AstraZeneca AB
INCERIFY
15日前
Tharimmune, Inc.
THARIMMUNE
22日前
Voyager Therapeutics, Inc.
VOYAGER
22日前
Boehringer Ingelheim International GmbH
15日前
SCM Lifescience, Inc.
GOVAHOD
22日前
Novartis AG
VIKVOBY
28日前
続きを見る